Close Menu

NEW YORK (GenomeWeb) –Vela Diagnostics announced today it has licensed two methods from the University of California, San Francisco for enriching rare sequences, and plans to use the technologies to develop oncology and infectious disease tests, including for cell-free DNA and RNA testing and microbiology tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.